Longer-term prognostic benefit of low-dose digoxin versus beta-blockers in patients with permanent atrial fibrillation and symptoms of heart failure

31 August 2026 (14:15 - 14:30)

Organised by:

About the speaker

Professor Dipak Kotecha

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail

Ablate versus Pace in Elderly Patients With Persistent Atrial Fibrillation

Professor J. Ehrlich (Wiesbaden, DE)

Presentation thumbnail

CANDLE-AF: Comparative effectiveness of noninvasive single-lead ECG monitoring strategies for atrial fibrillation detection after cryptogenic stroke

Doctor J. Park (Seoul, KR)

Presentation thumbnail

REAL-PATCH-AF: Real-world performance of self-applied ECG patch systems for atrial fibrillation screening in older adults: a randomized comparison of six systems

Doctor D. Pavluk (Innsbruck, AT)

Access the full session

Session thumbnail

Late-Breaking Clinical Trials: atrial fibrillation detection to treatment strategies

The Event

Event poster

ESC Congress 2026

31 August 2026 14:15 CET

You may be interested in

Congress Presentation

Digoxin vs. beta-blocker therapy in atrial fibrillation: analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry

27 August 2021

Congress Session

Arrhythmias and devices

17 May 2025

Congress Presentation

HFA Philip Poole Wilson Lecture - Digoxin in heart failure: the past, the present and the possible future

17 May 2025

Congress Presentation

The prognostic value of beta blocker dosage and heart rate at discharge among patients with acute decompensation of heart failure with reduced EF

29 June 2021

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources